Abstract The coronavirus disease (COVID-19) caused by a severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly worldwide. Given that this …

Myricetin (3, 5, 7, 3′, 4′, 5′-hexahydroxyflavone), a common dietary flavonoid, has been
reported for its roles in improving health due to various pharmacological activities, such as …

The portfolio of SARS-CoV-2 small molecule drugs is currently limited to a handful that are
either approved (remdesivir), emergency approved (dexamethasone, baricitinib, paxlovid …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent in the
humans since 2019 and has given rise to a pandemic situation. With the discovery and …

There are currently relatively few small-molecule antiviral drugs that are either approved or
emergency-approved for use against severe acute respiratory coronavirus 2 (SARS-CoV-2) …

The need for preparing new strategies for the design of emergency drug therapies against
COVID-19 and similar diseases in the future is rather urgent, considering the high rate of …

Background COVID19 patients may suffer from multiple cardiovascular complications.
Recently, N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) was a …

Elderly patients with cardiovascular diseases account for a large proportion of Corona virus
Disease 2019 (COVID-19) related deaths. COVID-19, as a new coronavirus, mainly targets …

COVID-19 patients have shown overexpressed serum levels of several pro-inflammatory
cytokines, leading to a high mortality rate due to numerous complications. Also, previous …

Abstract Coronavirus disease‐2019 (COVID‐19) is pro‐inflammatory disorder characterized
by acute respiratory distress syndrome. Interleukin‐6, a cytokine secreted by macrophages …